Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Breast Cancer Research

Fig. 2

From: Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial

Fig. 2

Correlations between absolute CTC count and downstream CTC characterization. a Correlation between the number of CTC detected and the number of CTC with interpretable FISH results. b Correlation, in the 14 patients with ≥ 1 HER2amp CTC at the screening step, between the number of (i) CTC, (ii) CTC with interpretable FISH result, and (iii) HER2amp CTC. b Correlation between the number of CTC detected and the number of JER2amp CTC for the 14 patients with ≥ 1 HERamp CTC detected. For each patient, the number of CTC with interpretable FISH results is shown in brackets.

Back to article page